Acadian Asset Management Portfolio holdings
AUM
$48.4B
1-Year Return
32.04%
This Quarter Return
+13.47%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$48.4B
AUM Growth
+$13.1B
(+37%)
Cap. Flow
+$9.2B
Cap. Flow
% of AUM
19%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
1,878
New
276
Increased
655
Reduced
560
Closed
216
Top Buys
| 1 |
NVIDIA
NVDA
|
+$651M |
| 2 |
Microsoft
MSFT
|
+$557M |
| 3 |
Salesforce
CRM
|
+$509M |
| 4 |
Apple
AAPL
|
+$405M |
| 5 |
Mastercard
MA
|
+$304M |
Top Sells
| 1 |
Spotify
SPOT
|
+$436M |
| 2 |
Barclays
BCS
|
+$202M |
| 3 |
On Holding
ONON
|
+$186M |
| 4 |
Philip Morris
PM
|
+$142M |
| 5 |
Citigroup
C
|
+$132M |
Sector Composition
| 1 | Technology | 34.96% |
| 2 | Communication Services | 14.74% |
| 3 | Financials | 13.4% |
| 4 | Healthcare | 10.58% |
| 5 | Consumer Discretionary | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Hanover Bancorp
HNVR
$162M
| $412K | ﹤0.01% |
18,156
+8,758
| +93% | +$199K |
|
1177
SR Bancorp
SRBK
$122M
| $412K | ﹤0.01% |
30,613
-16,337
| -35% | -$220K |
|
1178
Data I/O
DAIO
$31.6M
| $408K | ﹤0.01% |
133,221
-13,319
| -9% | -$40.8K |
|
1179
VICI Properties
VICI
$35.4B
| $407K | ﹤0.01% |
12,499
-44,442
| -78% | -$1.45M |
|
1180
World Kinect Corp
WKC
$1.41B
| $407K | ﹤0.01% |
14,418
-54,337
| -79% | -$1.53M |
|
|
CBNA
1181
Chain Bridge Bancorp, Inc.
CBNA
$206M
| $407K | ﹤0.01% |
16,011
+10,431
| +187% | +$265K |
|
1182
Neurocrine Biosciences
NBIX
$14.1B
| $404K | ﹤0.01% |
3,228
+174
| +6% | +$21.8K |
|
1183
NL Industries
NL
$295M
| $403K | ﹤0.01% |
63,269
-17,399
| -22% | -$111K |
|
1184
Idexx Laboratories
IDXX
$51.3B
| $399K | ﹤0.01% |
746
-1,775
| -70% | -$949K |
|
1185
Generation Bio
GBIO
$39.9M
| $393K | ﹤0.01% |
123,347
+7,433
| +6% | +$23.7K |
|
1186
Innospec
IOSP
$2.05B
| $393K | ﹤0.01% |
4,685
+1,821
| +64% | +$153K |
|
1187
Avery Dennison
AVY
$12.9B
| $392K | ﹤0.01% |
2,239
| – | – |
|
1188
Pacira BioSciences
PCRX
$1.22B
| $390K | ﹤0.01% |
+16,416
| New | +$390K |
|
|
NUTX
1189
Nutex Health
NUTX
$540M
| $389K | ﹤0.01% |
+3,130
| New | +$389K |
|
1190
Viavi Solutions
VIAV
$2.69B
| $388K | ﹤0.01% |
38,543
| – | – |
|
1191
Dollar Tree
DLTR
$19.9B
| $386K | ﹤0.01% |
3,909
-57,791
| -94% | -$5.71M |
|
1192
Huazhu Hotels Group
HTHT
$11.4B
| $384K | ﹤0.01% |
+11,328
| New | +$384K |
|
|
MSIF
1193
MSC Income Fund, Inc.
MSIF
$669M
| $384K | ﹤0.01% |
+23,454
| New | +$384K |
|
1194
Remitly
RELY
$3.74B
| $382K | ﹤0.01% |
+20,427
| New | +$382K |
|
1195
Cross Country Healthcare
CCRN
$411M
| $374K | ﹤0.01% |
28,660
-57,412
| -67% | -$749K |
|
1196
Agilon Health
AGL
$443M
| $372K | ﹤0.01% |
+163,835
| New | +$372K |
|
1197
Passage Bio
PASG
$22.3M
| $372K | ﹤0.01% |
46,688
| – | – |
|
1198
Relmada Therapeutics
RLMD
$52.8M
| $371K | ﹤0.01% |
619,479
-608,449
| -50% | -$364K |
|
|
ALEX
1199
Alexander & Baldwin
ALEX
$1.34B
| $370K | ﹤0.01% |
+20,810
| New | +$370K |
|
1200
Assembly Biosciences
ASMB
$168M
| $369K | ﹤0.01% |
20,421
-2,606
| -11% | -$47.1K |
|